Search EN menu en EIB GROUP CLIENT PORTAL
Close EIB GROUP CLIENT PORTAL
Search
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

TECHEU TI LS & BIOTECH ACT (IEU VD) LE III

Summary sheet

Release date
19 March 2026
Status
Reference
Under appraisal | 17/02/2026
20250871
Project name
Promoter - financial intermediary
TECHEU TI LS & BIOTECH ACT (IEU VD) LE III
ACCEPTABLE CORPORATE(S)
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 500 million
EUR 1000 million
Location
Sector(s)
Description
Objectives

The project refers to a Lending Envelope for investments comprising Thematic Venture Debt (Equity Type) operations eligible under the Thematic Innovation - Research, Innovation and Digitalisation Window (RIDW) InvestEU Window, including: 1.1. Health Innovation; and 1.3 Areas of strategic importance, as well as any additional requirement defined by the specific financing sources part of the Envelope. Previously, these operations under Thematic Innovation were included in 2023-0791 TechEU Thematic Innovation (InvestEU VD) LE II, which included Health Innovation, Future Tech and Areas of strategic importance. A separate Lending Envelope is expected for Future Tech (2025-0870 - TECHEU TI TECH (INVESTEU VD) LE III).

The aim is to provide venture debt finance to eligible counterparts in all InvestEU eligible countries.

Environmental aspects
Procurement

Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate

Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate

Milestone
Under appraisal

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

Related publications